Essential Premium Newsletter Institutional Investor stories focused on hedge funds and alternatives. December 31, 2023 This email is sent out twice a week and covers hedge fund related topics.View a sample Related Articles Premium Biopharma Hedge Funds Rebounded Sharply Last Month — But Is It Sustainable? Stephen Taub August Surge Offers Relief to Managed Futures Funds — But Not Redemption Stephen Taub II Communities on Alternative Investments Sponsored by Fidelity Investments